🇺🇸 FDA
Patent

US 10137100

Administration of serine protease inhibitors to the stomach

granted A61KA61K31/10A61K31/145

Quick answer

US patent 10137100 (Administration of serine protease inhibitors to the stomach) held by The Regents of the University of California expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/10, A61K31/145, A61K31/155, A61K31/185